Sonoma Pharmaceuticals第一季度运营支出达260万美元

投资观察
Aug 06

Sonoma Pharmaceuticals(股票代码:SNOA)在2026年第一季度业绩报告中披露,其运营支出为260万美元。与此同时,该公司第一季度的EBITDA(税息折旧及摊销前利润)录得10万美元。这一财务数据于8月6日发布,展现了公司在成本控制与盈利能力方面的最新动态。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10